Clinical Trial Update: Study to Assess the Efficacy and Safety of Transplanting Autologous Skeletal Myoblasts, Into Infarcted Heart, Using an Catheter Delivery System [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial aims to assess the efficacy and safety of transplanting autologous skeletal myoblasts into infarcted heart tissue using a catheter d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Cardiomyopathy

Drugs mentioned

• Autologous Skeletal Myoblasts

Snippet

Sponsor: Mytogen, Inc. | Conditions: Ischemic Cardiomyopathy | Phase 2 | Status: UNKNOWN